Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
48 hedge funds and large institutions have $191M invested in Applied Genetic Technologies Corporation in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
84% more capital invested
Capital invested by funds: $104M → $191M (+$87M)
55% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 11
14% more funds holding
Funds holding: 42 → 48 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.41M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$4.56M |
| 5 |
Millennium Management
New York
|
+$4.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$929K |
| 2 |
Citigroup
New York
|
-$721K |
| 3 |
JP Morgan Chase
New York
|
-$488K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$481K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$326K |
AGTC Hedge Fund Activity: Q4 2014 in Review
48 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2014, worth a combined $191M — up 84% from $104M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AGTC positions and 6 closed out — a net gain of 7 holders — while 17 added to existing stakes and 11 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11.8M. The largest seller was Sphera Funds Management, cutting an estimated $929K.
- 48 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2014, up from 42 in Q3 2014.
- Funds reported $191M of Applied Genetic Technologies Corporation stock for Q4 2014, up 84% quarter-over-quarter.
- 13 funds opened new Applied Genetic Technologies Corporation positions in Q4 2014 and 6 closed out, a net change of +7 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q4 2014 was Fidelity Investments, an estimated $11.8M added.
- The largest Applied Genetic Technologies Corporation seller in Q4 2014 was Sphera Funds Management, an estimated $929K sold.
Based on aggregated 13F filings for Q4 2014.